BioCentury
ARTICLE | Clinical News

Alphanate regulatory update

February 12, 2007 8:00 AM UTC

FDA approved an sBLA for Alphanate antihemophilic factor/ von Willebrand factor complex for patients undergoing surgery or invasive procedures with von Willebrand disease (vWD) in whom desmopressin i...